Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20


The Effects of Lowering Uric Acid Levels Using Allopurinol on Components of Metabolic Syndrome.

Heimbach EJ, Bowden RG, Griggs JO, Beaujean AA, Doyle EI, Doyle RD.

Cardiol Res. 2012 Apr;3(2):80-86. doi: 10.4021/cr168w. Epub 2012 Mar 20.


Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis.

Zhang J, Dierckx R, Mohee K, Clark AL, Cleland JG.

ESC Heart Fail. 2017 Feb;4(1):40-45. doi: 10.1002/ehf2.12112. Epub 2016 Sep 20.


The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats.

Al-Zahrani YA, Al-Harthi SE, Khan LM, El-Bassossy HM, Edris SM, A Sattar MA.

Saudi Pharm J. 2015 Oct;23(5):487-98. doi: 10.1016/j.jsps.2014.12.001. Epub 2015 Jan 7.


Liver Enzymes and Uric acid in Acute Heart Failure.

Vakilian F, Rafighdoost AA, Rafighdoost AH, Amin A, Salehi M.

Res Cardiovasc Med. 2015 Sep 26;4(4):e22988. doi: 10.5812/cardiovascmed.4(2)2015.22988. eCollection 2015 Nov.


Relationship between red cell distribution width and serum uric acid in patients with untreated essential hypertension.

Luo M, Li ZZ, Li YY, Chen LZ, Yan SP, Chen P, Hu YY.

Sci Rep. 2014 Dec 3;4:7291. doi: 10.1038/srep07291.


Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study.

Kok VC, Horng JT, Chang WS, Hong YF, Chang TH.

PLoS One. 2014 Jun 4;9(6):e99102. doi: 10.1371/journal.pone.0099102. eCollection 2014.


Cardiac metabolism in heart failure: implications beyond ATP production.

Doenst T, Nguyen TD, Abel ED.

Circ Res. 2013 Aug 30;113(6):709-24. doi: 10.1161/CIRCRESAHA.113.300376. Review.


Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals.

Skak-Nielsen H, Torp-Pedersen C, Finer N, Caterson ID, Van Gaal L, James WP, Maggioni AP, Sharma AM, Coutinho W, Andersson C.

PLoS One. 2013;8(3):e59121. doi: 10.1371/journal.pone.0059121. Epub 2013 Mar 22.


Gout and the risk for incident heart failure and systolic dysfunction.

Krishnan E.

BMJ Open. 2012 Feb 15;2(1):e000282. doi: 10.1136/bmjopen-2011-000282. Print 2012.


Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease.

Kao MP, Ang DS, Gandy SJ, Nadir MA, Houston JG, Lang CC, Struthers AD.

J Am Soc Nephrol. 2011 Jul;22(7):1382-9. doi: 10.1681/ASN.2010111185. Epub 2011 Jun 30.


Impact of allopurinol use on urate concentration and cardiovascular outcome.

Wei L, Mackenzie IS, Chen Y, Struthers AD, MacDonald TM.

Br J Clin Pharmacol. 2011 Apr;71(4):600-7. doi: 10.1111/j.1365-2125.2010.03887.x.


Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure.

Park HS, Kim H, Sohn JH, Shin HW, Cho YK, Yoon HJ, Nam CW, Hur SH, Kim YN, Kim KB, Park HJ.

Korean J Intern Med. 2010 Sep;25(3):253-9. doi: 10.3904/kjim.2010.25.3.253. Epub 2010 Aug 31.


The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease.

Higgins P, Dawson J, Walters M.

Cardiovasc Psychiatry Neurol. 2009;2009:282059. doi: 10.1155/2009/282059. Epub 2009 Nov 4.


Hyperuricemia and incident heart failure.

Krishnan E.

Circ Heart Fail. 2009 Nov;2(6):556-62. doi: 10.1161/CIRCHEARTFAILURE.108.797662. Epub 2009 Aug 6.


Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Arnold JM, Howlett JG, Dorian P, Ducharme A, Giannetti N, Haddad H, Heckman GA, Ignaszewski A, Isaac D, Jong P, Liu P, Mann E, McKelvie RS, Moe GW, Parker JD, Svendsen AM, Tsuyuki RT, O'Halloran K, Ross HJ, Rao V, Sequeira EJ, White M.

Can J Cardiol. 2007 Jan;23(1):21-45. Review.


Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

Ungvári Z, Gupte SA, Recchia FA, Bátkai S, Pacher P.

Curr Vasc Pharmacol. 2005 Jul;3(3):221-9. Review.


Hyperuricaemia does not impair cardiovascular function in healthy adults.

Waring WS, Adwani SH, Breukels O, Webb DJ, Maxwell SR.

Heart. 2004 Feb;90(2):155-9.

Supplemental Content

Support Center